Iridius | $8,600,000 | (Apr 28, 2026)
Audion | $15,000,000 | (Apr 28, 2026)
Decade Energy | $25,763,540 | (Apr 28, 2026)
Certified by Founder
Lodge
TRIMTECH Therapeutics Limited
start up
United Kingdom
- Cambridge, England
- 07/03/2025
- Seed
- $31,000,000
TRIMTECH has a growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs and TRIMGLUEs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.
- Industry Biotechnology Research
- Website https://trimtechtherapeutics.com/
- LinkedIn https://www.linkedin.com/company/trimtech-therapeutics-limited/
TriFetch | $1,900,000 | (Apr 28, 2026)
Fathom Therapeutics | $47,000,000 | (Apr 28, 2026)
SquareMind | $18,000,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)
Cnuic Technologies | $3,000,000 | (Apr 28, 2026)
Zócalo Health | $15,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)